Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Femasys Inc.

Market Cap 12.2M 10.64M 9.85M 9.22M 17.29M 1.15B 17.4M 117M 45.29M 567M 45.79M 44.81M 1.97B P/E 2026 *
-0.89x
P/E 2027 * -0.74x
Enterprise Value 12.2M 10.64M 9.85M 9.22M 17.29M 1.15B 17.4M 117M 45.29M 567M 45.79M 44.81M 1.97B EV / Sales 2026 *
3.24x
EV / Sales 2027 * 1.22x
Free-Float
90.43%
Yield 2026 *
-
Yield 2027 * -
1 day-3.58%
1 week-3.35%
Current month-47.80%
1 month-40.11%
3 months-63.76%
6 months-76.54%
Current year-64.94%
1 week 3.77
Extreme 3.77
4.49
1 month 3.77
Extreme 3.77
10.56
Current year 3.77
Extreme 3.77
14.51
1 year 3.77
Extreme 3.77
22.2
3 years 3.77
Extreme 3.77
95
5 years 3.77
Extreme 3.77
215.8
10 years 3.77
Extreme 3.77
275
Manager TitleAgeSince
Chief Executive Officer 59 2003-12-31
Director of Finance/CFO 58 2022-02-27
Chief Operating Officer 52 2026-03-29
Director TitleAgeSince
Chairman 74 2022-07-05
Chairman 59 2003-12-31
Director/Board Member 75 2005-07-31
Date Insider Type Main position Quantity % Market Cap.
03-29Other

Chief Operating Officer

30,000 0.0504%
03-29Free

Chief Operating Officer

150,000 0.2521%
03-18Free

Director

102,366 0.1720%
Change 5-day change 1-year change 3-year change Capi.($)
-3.58%-3.35%-76.24%-64.50% 12.2M
-0.10%+0.26%-33.52%-16.79% 154B
+1.54%-1.07%-8.11%-10.17% 102B
-0.62%+1.65%+59.14%+59.05% 56.51B
-1.90%-3.49%-7.43%+46.28% 52.89B
+1.67%-1.55%-14.51%-44.04% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-43.32% 27.96B
+1.35%-0.26%+51.96%-11.10% 23.17B
+1.01%+0.51%-15.94%-3.41% 20.35B
Average -0.02%-2.72%-6.01%-9.78% 50.65B
Weighted average by Cap. +0.26%-1.24%-6.29%-2.35%

Financials

2026 *2027 *
Net sales 3.77M 3.28M 3.04M 2.85M 5.34M 355M 5.37M 36.08M 13.98M 175M 14.14M 13.83M 607M 10M 8.72M 8.08M 7.56M 14.18M 944M 14.27M 95.82M 37.13M 465M 37.54M 36.74M 1.61B
Net income -16.22M -14.14M -13.1M -12.26M -22.99M -1.53B -23.13M -155M -60.22M -753M -60.88M -59.58M -2.62B -21.29M -18.56M -17.19M -16.09M -30.18M -2.01B -30.36M -204M -79.03M -989M -79.9M -78.19M -3.43B
Net Debt - -
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
26-06-18 4.040 $ -3.58% 43,802
26-06-17 4.190 $ +9.11% 59,649
26-06-16 3.840 $ -3.52% 54,519
26-06-15 3.980 $ -4.78% 98,333
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.040USD
Average target price
63.33USD
Spread / Average Target
+1,467.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FEMY Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!